Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- MED +11.1%, ADSK +9.9%, TRVN +7.9%, BOJA +7.6%, MOMO +6.8%, ANF +5.4%,ZFGN +5.2%, (also announces positive interim data from ongoing ZGN-1061 Phase 2 proof-of-concept trial in patients with Type 2 Diabetes ), PFMT +4.8%, HRB +4.8%,TTPH +4.7%, PTCT +4.3%, HCI +4.1%, BXG +4%, NCS +2.5%, KFY +2.1%, GWRE+0.9%, SHIP +0.9%
Select metals/mining stocks trading higher:
- X +1.7%, AKS +1.4%, NUE +1.2%, CENX +0.8%, STLD +0.5%
Other news:
- APTO +16% (announces exclusive global license agreement with OHM Oncology)
- FORM +6.3% (will replace Calgon Carbon in the S&P SmallCap 600)
- CLSD +5.8% (also announced plans for $75 mln common stock offering)
Analyst comments:
- VOD +0.5% (upgraded to Outperform from Neutral at Exane BNP Paribas)